KARL STORZ Endoscopy-America, Inc., a leading name in the medical technology sector, is headquartered in the United States and operates extensively across North America. Founded in 1945, the company has established itself as a pioneer in endoscopic equipment, providing innovative solutions for various medical fields, including surgery, gastroenterology, and urology. Renowned for its high-quality endoscopic instruments and imaging systems, KARL STORZ is committed to advancing minimally invasive procedures. The company’s unique approach combines cutting-edge technology with a deep understanding of clinical needs, ensuring superior performance and reliability. With a strong market position, KARL STORZ has received numerous accolades for its contributions to healthcare, solidifying its reputation as a trusted partner for medical professionals worldwide.
How does KARL STORZ Endoscopy-America, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
KARL STORZ Endoscopy-America, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
KARL STORZ Endoscopy-America, Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as no emissions figures are available. The company is a current subsidiary of KARL STORZ SE & Co. KG, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from KARL STORZ Endoscopy-America, Inc. This absence of data suggests that the company may still be in the early stages of establishing its carbon reduction strategies or may rely on broader corporate initiatives from its parent company. Given the lack of specific emissions data and reduction initiatives, it is essential for KARL STORZ Endoscopy-America, Inc. to develop and communicate clear climate commitments to align with industry standards and expectations. This would not only enhance transparency but also contribute to global efforts in mitigating climate change.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | -  | 
| Scope 2 | 1,091  | 
| Scope 3 | -  | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
KARL STORZ Endoscopy-America, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
